Anli Tong
Peking Union Medical College Hospital
6
5
2
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Andrea B Apolo, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Mingwei Huang, MD
Jinhua Central Hospital
Shared therapeutic areas:
Shivaani Kummar, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Yi Wang, MD
First People's Hospital of Hangzhou
Shared therapeutic areas:
Yukang Song, MD
Affiliated Wenling Hospital of Wenzhou Medical University
Shared therapeutic areas:
Lukasz Szarpak
Institute of Cardiology
Shared therapeutic areas:
Fuzheng Tao, MD
Taizhou Hospital of integrated traditional Chinese and Western Medicine
Shared therapeutic areas:
Guojuan Ding, MD
Shaoxing People's Hospital
Shared therapeutic areas:
Dengpan Lai, MD
Affiliated Hospital of Hangzhou Teacher's University
Shared therapeutic areas:
Yingru Lu, MD
First Affiliated Hospital of Wenzhou Medical University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL
The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment
Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients
A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL
The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma
The Efficacy and Safety of Temozolomide in Patients With MPPGL
All 6 trials loaded